Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1681/ASN.2015050528 http://scihub22266oqcxt.onion/10.1681/ASN.2015050528 C4769209!4769209!26319242     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Am+Soc+Nephrol 2016 ; 27 (3): 666-76 Nephropedia Template TP {{tp|p=26319242|t=2016. PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes |pdf=|usr=}}{{26319242}} gab.com Text PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes JO: J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=26319242 #FOAvip An important measure of cardiovascular health is obtained by evaluating the global cardiovascular risk, which comprises a number of factors, including hypertension and type 2 diabetes, the leading causes of illness and death in the world, as well as the metabolic syndrome. Altered immunity, inflammation, and oxidative stress underlie many of the changes associated with cardiovascular disease, diabetes, and the metabolic syndrome, and recent efforts have begun to elucidate the contribution of PGE2 in these events. This review summarizes the role of PGE2 in kidney disease outcomes that accelerate cardiovascular disease, highlights the role of cyclooxygenase-2/microsomal PGE synthase 1/PGE2 signaling in hypertension and diabetes, and outlines the contribution of PGE2 to other aspects of the metabolic syndrome, particularly abdominal adiposity, dyslipidemia, and atherogenesis. A clearer understanding of the role of PGE2 could lead to new avenues to improve therapeutic options and disease management strategies. Twit Text FOAVip PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes ????J Am Soc Nephrol http://www.kidney.de/pget.php?&tw=1&pmid=26319242 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26319242 #FOAvip English Wikipedia <ref>{{Cite pmid|26319242}}</ref> PGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes #MMPMID26319242 Nasrallah R; Hassouneh R; Hébert RL J Am Soc Nephrol 2016[Mar]; 27 (3): 666-76 PMID26319242show ga An important measure of cardiovascular health is obtained by evaluating the global cardiovascular risk, which comprises a number of factors, including hypertension and type 2 diabetes, the leading causes of illness and death in the world, as well as the metabolic syndrome. Altered immunity, inflammation, and oxidative stress underlie many of the changes associated with cardiovascular disease, diabetes, and the metabolic syndrome, and recent efforts have begun to elucidate the contribution of PGE2 in these events. This review summarizes the role of PGE2 in kidney disease outcomes that accelerate cardiovascular disease, highlights the role of cyclooxygenase-2/microsomal PGE synthase 1/PGE2 signaling in hypertension and diabetes, and outlines the contribution of PGE2 to other aspects of the metabolic syndrome, particularly abdominal adiposity, dyslipidemia, and atherogenesis. A clearer understanding of the role of PGE2 could lead to new avenues to improve therapeutic options and disease management strategies. äPGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and(epmc).pdf DeepDyve Pubget Overpricing